99 related articles for article (PubMed ID: 16863909)
1. Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system.
Kim CH
Exp Hematol; 2006 Aug; 34(8):1033-40. PubMed ID: 16863909
[TBL] [Abstract][Full Text] [Related]
2. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues.
Lee JH; Kang SG; Kim CH
J Immunol; 2007 Jan; 178(1):301-11. PubMed ID: 17182567
[TBL] [Abstract][Full Text] [Related]
3. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
Schneider MA; Meingassner JG; Lipp M; Moore HD; Rot A
J Exp Med; 2007 Apr; 204(4):735-45. PubMed ID: 17371928
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue.
Kocks JR; Davalos-Misslitz AC; Hintzen G; Ohl L; Förster R
J Exp Med; 2007 Apr; 204(4):723-34. PubMed ID: 17371929
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease.
Li H; Guo Z; Jiang X; Zhu H; Li X; Mao N
Stem Cells; 2008 Oct; 26(10):2531-41. PubMed ID: 18635870
[TBL] [Abstract][Full Text] [Related]
7. CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.
Ueha S; Yoneyama H; Hontsu S; Kurachi M; Kitabatake M; Abe J; Yoshie O; Shibayama S; Sugiyama T; Matsushima K
J Leukoc Biol; 2007 Nov; 82(5):1230-8. PubMed ID: 17698914
[TBL] [Abstract][Full Text] [Related]
8. Trafficking of FoxP3+ regulatory T cells: myths and facts.
Kim CH
Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143
[TBL] [Abstract][Full Text] [Related]
9. Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
de Jager SC; Canté-Barrett K; Bot I; Husberg C; van Puijvelde GH; van Santbrink PJ; Yndestad A; van den Oever JM; Kuiper J; van Berkel TJ; Lipp M; Zwaginga JJ; Fibbe WE; Aukrust P; Biessen EA
Transplantation; 2009 Sep; 88(5):631-9. PubMed ID: 19741459
[TBL] [Abstract][Full Text] [Related]
10. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
[TBL] [Abstract][Full Text] [Related]
12. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
Campbell DJ; Ziegler SF
Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
[TBL] [Abstract][Full Text] [Related]
14. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
16. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
[TBL] [Abstract][Full Text] [Related]
17. Recent thymic origin, differentiation, and turnover of regulatory T cells.
Mabarrack NH; Turner NL; Mayrhofer G
J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
19. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]